Son Daegu, Harijan Aram
Department of Plastic and Reconstructive Surgery, Keimyung University School of Medicine, Daegu, Korea.
Well Plastic Surgery Clinic, Seoul, Korea.
J Korean Med Sci. 2014 Jun;29(6):751-7. doi: 10.3346/jkms.2014.29.6.751. Epub 2014 May 30.
Management of incisional scar is intimately connected to stages of wound healing. The management of an elective surgery patient begins with a thorough informed consent process in which the patient is made aware of personal and clinical circumstances that cannot be modified, such as age, ethnicity, and previous history of hypertrophic scars. In scar prevention, the single most important modifiable factor is wound tension during the proliferative and remodeling phases, and this is determined by the choice of incision design. Traditional incisions most often follow relaxed skin tension lines, but no such lines exist in high surface tension areas. If such incisions are unavoidable, the patient must be informed of this ahead of time. The management of a surgical incision does not end when the sutures are removed. Surgical scar care should be continued for one year. Patient participation is paramount in obtaining the optimal outcome. Postoperative visits should screen for signs of scar hypertrophy and has a dual purpose of continued patient education and reinforcement of proper care. Early intervention is a key to control hyperplastic response. Hypertrophic scars that do not improve by 6 months are keloids and should be managed aggressively with intralesional steroid injections and alternate modalities.
手术切口瘢痕的管理与伤口愈合阶段密切相关。对于择期手术患者的管理始于全面的知情同意过程,在此过程中,患者要了解一些无法改变的个人和临床情况,如年龄、种族以及既往肥厚性瘢痕病史。在瘢痕预防方面,增殖期和重塑期最重要的可改变因素是伤口张力,而这取决于切口设计的选择。传统切口大多沿着皮肤松弛张力线,但在高表面张力区域不存在这样的线。如果不可避免要做这样的切口,必须提前告知患者。手术切口的管理在缝线拆除后并未结束。手术瘢痕护理应持续一年。患者的参与对于获得最佳效果至关重要。术后随访应筛查瘢痕增生的迹象,其具有持续患者教育和强化正确护理的双重目的。早期干预是控制增生反应的关键。6个月内未改善的肥厚性瘢痕是瘢痕疙瘩,应积极采用病灶内注射类固醇及其他方法进行处理。